Orthodontic Screening in Public Healthcare
Launched by UNIVERSITY OF HELSINKI · Jun 14, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on studying how orthodontic screenings—checks for dental alignment—are conducted in public healthcare settings. The goal is to understand current practices and see how they can be improved to help people with malocclusion, which is when teeth are not aligned properly.
The study is open to individuals aged between 6 to 16 years who live in the specified area and are willing to participate. If selected, participants will fill out a questionnaire to share their experiences and opinions about orthodontic care. It's important to note that younger children under 6 or those over 16, as well as individuals who may struggle to understand the questions due to language barriers, will not be eligible for this study. If you or someone you know fits the criteria and is interested in helping improve orthodontic care, this trial might be a great opportunity!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • residence in the wellbeing services county catchment area
- • willingness to participate in the study
- Exclusion Criteria:
- • Age under 6 years or over 16 years
- • insufficient language skills to be able to understand the questionnaire
About University Of Helsinki
The University of Helsinki, a prestigious institution in Finland, is dedicated to advancing health sciences through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, the university engages in cutting-edge studies that aim to improve patient outcomes and contribute to the global knowledge base in medicine. Its commitment to ethical standards and rigorous methodology ensures the integrity and reliability of its clinical research initiatives, making it a key player in the development of novel therapeutic strategies and healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Helsinki, , Finland
Vantaa, , Finland
Patients applied
Trial Officials
Heidi Arponen
Study Director
University of Helsinki
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported